Executive Summary
According to Azoth Analytics research report published in September 2022, the global Pain Management Drugs market was valued at USD 82.12 million in the year 2021 with Americas leading the regional market share.
The global Pain Management Drugs Market is driven by an increasing number of Chronic Pain diseases and the prevalence of cancer pain worldwide. Additionally, a growing population in which the number of geriatric population is high in several developing countries is anticipated to propel the growth of the global Pain Management drugs market.
Additionally, life expectancy has increased due to various healthcare reforms in major economies such as the U.S., Japan, and China. This is likely to drive demand for many Pain Management drugs for advanced stages of cancer, chronic pain conditions and post-operative pain management drugs.
The COVID- 19 pandemic had a mixed impact on the Global Pain Management Drugs market by affecting the drug supply chain dramatically which led to hindrances in the production and sale of opiates which are the most prominent Pain management drug in the market in key producing countries such as Afghanistan and Myanmar. Paracetamol was recommended for use by various healthcare authorities across the world, to manage fever and mild pain in adults and children with COVID-19, which boosted the demand for the drug. Moreover, India and China being the chief API suppliers for Paracetamol drugs were unable to supply the APIs due to restrictions imposed due to COVID -19 which led to manufacturing restraints and shortages in many European countries.
Scope of the Report
• The report presents insights on the 28 major drug development pipelines for Pain Management.
• The report presents the analysis of the Pain Management Drugs Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
• The report analyses the Pain Management Drugs Market by Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics, Others).
• The report analyses the Pain Management Drugs Market by Route of Administration (Topical, Intravenous, Oral, Others).
• The report analyses the Pain Management Drugs Market by End-use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain).
• The report analyses the Pain Management Drugs Market by Availability (Over the Counter (OTC), Prescription).
• The report analyses the Pain Management Drugs Market by Sales Channel (Retail Pharmacies, Hospital Pharmacies and E-commerce).
• The Global Pain Management Drugs Market has been analysed By Region (Americas, Europe, Asia Pacific, and MEA).
• The Global Pain Management Drugs Market has been analysed By Country (United States, Canada, Germany, U.K, France, Spain, Italy, China, Japan and India).
• The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Drug Class, by Indication, by End User, by Formulation, and by Distribution Channel.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Pfizer, Johnson and Johnson, GSK Plc., Bristol-Myers Squibb, AbbVie, Bayer, Boehringer Ingelheim, Novartis, Teva Pharmaceutical, Sanofi, Amgen.
Key Target Audience
• Pain Management Drugs Companies
• Healthcare and Pharmaceutical Companies
• Research and Development (R&D) Organizations
• Government Bodies & Regulating Authorities
• Investment Banks and Equity Firms
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Pain Management Drugs Market: Product Overview
4. Global Pain Management Drugs Market: Pipeline Analysis
4.1. Competitive Positioning of Prominent companies with Pain management Drugs in their Pipeline
4.2 Investigational New Drug
4.2.1 Basimglurant (NOE-101), Drug Description and Outcomes
4.3 Phase I
4.3.1 Resiniferatoxin (RTX), Drug Description and Outcomes
4.3.2 VX-548, Drug Description and Outcomes
4.4 Phase - II/III
4.4.1 TLC590, Bupivacaine, Drug Description and Outcomes
4.5 Phase II
4.5.1 BAY2395840, Drug Description and Outcomes
4.5.2 Libvatrep- SAF312, Drug Description and Outcomes
4.5.3 Trametinib, Drug Description and Outcomes
4.5.4 Canakinumab + LNA043, Drug Description and Outcomes
4.5.5 Erenumab-aooe (EREN), Drug Description and Outcomes
4.5.6 Erenumab-Aooe (AimovigÆ), Drug Description and Outcomes
4.5.7 Erenumab-Aooe 70 MG, Drug Description and Outcomes
4.5.8 BOTOX (onabotulinumtoxinA) , Drug Description and Outcomes
4.5.9 Resiniferatoxin, Drug Description and Outcomes
4.5.10 Resiniferatoxin, Zilretta, Drug Description and Outcomes
4.5.11 LY3526318, Drug Description and Outcomes
4.5.12 LY3526318, Drug Description and Outcomes
4.5.13 Quinagolide (FE 999051), Drug Description and Outcomes
4.5.14 HMI-115, Drug Description and Outcomes
4.6 Phase III
4.6.1 Secukinumab, Drug Description and Outcomes
4.6.2 Venglustat (GZ402671) , Drug Description and Outcomes
4.6.3 Elagolix + Estradiol/Norethindrone Acetate, Drug Description and Outcomes
4.6.4 Elagolix + Combined Oral Contraceptive (COC), Drug Description and Outcomes
4.6.5 Ibuprofen PR (300 mg and 200 mg), Drug Description and Outcomes
4.6.6 Ibuprofen Liquid Capsules (200 mg), Drug Description and Outcomes
4.6.7 Intravenous (IV) tramadol (AVE-901), Drug Description and Outcomes
4.7 Phase IV
4.7.1 Catapresan, Drug Description and Outcomes
4.7.2 Ubrogepant 50 MG, 100MG, Drug Description and Outcomes Galcanezumab, Drug Description and Outcomes Erenumab Prefilled Syringe, Drug Description and Outcomes
5. Global Pain Management Drugs Market: An Analysis
5.1. Assessment of Macro-Economic Indicators of Global Pain Management Drugs Market
5.2. Pain Management Drugs Market
5.3 Market Size, By Value, 2018-2028
5.4 Global Pain Management Drugs Market: Growth and Forecast
5.5 Impact of COVID-19 on Global Pain Management Drugs Market
6. Global Pain Management Drugs Market: Segment Analysis By Drug Type
6.1 Global Pain Management Drugs Market Segmentation, By Drug Type
6.2 Competitive Positioning of Pain Management Drugs Market: By Drug Type (2021 & 2028)
6.3 By Acetaminophen, By Value (USD Million), 2018-2028
6.4 By NSAIDs, By Value (USD Million), 2018-2028
6.5 By Narcotics (opioids), By Value (USD Million), 2018-2028
6.6 By Others, By Value (USD Million), 2018-2028
7. Global Pain Management Drugs Market: Segment Analysis By Route of Administration
7.1 Global Pain Management Drugs Market Segmentation, By Route of Administration
7.2 Competitive Positioning of Pain Management Drugs Market: By Route of Administration (2021 & 2028)
7.3 By Topical, By Value (USD Million), 2018-2028
7.4 By Intravenous, By Value (USD Million), 2018-2028
7.5 By Oral, By Value (USD Million), 2018-2028
7.6 By Others, By Value (USD Million), 2018-2028
8. Global Pain Management Drugs Market: Segment Analysis By End Use
8.1 Global Pain Management Drugs Market Segmentation, By End Use
8.2 Competitive Positioning of Pain Management Drugs Market: By End Use (2021 & 2028)
8.3 By Inflammation, By Value (USD Million), 2018-2028
8.4 By Neuropathic Pain, By Value (USD Million), 2018-2028
8.5 By Musculoskeletal Pain, By Value (USD Million), 2018-2028
8.6 By Severe and Chronic Pain, By Value (USD Million), 2018-2028
9. Global Pain Management Drugs Market: Segment Analysis By Availability
9.1 Global Pain Management Drugs Market Segmentation, By Availability
9.2 Competitive Positioning of Pain Management Drugs Market: By Availability (2021 & 2028)
9.3 By Prescription, By Value (USD Million), 2018-2028
9.4 By Over The Counter (OTC), By Value (USD Million), 2018-2028
10. Global Pain Management Drugs Market: Segment Analysis
10.1 Global Pain Management Drugs Market Segmentation, By Sales Channel
10.2 Competitive Positioning of Pain Management Drugs Market: By Sales Channel (2021 & 2028)
10.3 By Hospital Pharmacies, By Value (USD Million), 2018-2028
10.4 By Retail Pharmacies, By Value (USD Million), 2018-2028
10.5 By E-commerce, By Value (USD Million), 2018-2028
11. Global Pain Management Drugs Market: Regional Analysis
11.1 Competitive Positioning of Global Pain Management Drugs Market: By Region (2021 & 2028)
12. Americas Pain Management Drugs Market: An Analysis (2018-2028)
12.1 Assessment of Macro-Economic Indicators of Americas Pain Management Drugs Market
12.2 Americas Pain Management Drugs Market- Size and Forecast, By Value (2018-2028)
12.3 Americas Pain Management Drugs Market
12.4 Americas Pain Management Drugs Market: Prominent Companies
12.5 Americas Pain Management Drugs Market: Segment Analysis
12.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value
12.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
12.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
12.9 Market Segmentation By Availability (OTC, Prescription), By Value
12.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
12.13 Americas Pain Management Drugs Market: Country Analysis
12.14 Market Opportunity Chart of Americas Pain Management Drugs Market - By Country, By Value (Year-2028)
12.15 Competitive Positioning of Americas Pain Management Drugs Market - By Country
12.16 United States Pain Management Drugs Market: Size and Forecast (2018-2028)
12.17 United States Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration, By End use, By Availability By Sales Channel (2018-2028)
12.18 Canada Pain Management Drugs Market: Size and Forecast (2018-2028)
12.19 Canada Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
13. Europe Pain Management Drugs Market: An Analysis (2018-2028)
13.1 Assessment of Macro-Economic Indicators of Europe Pain Management Drugs Market
13.2 Europe Pain Management Drugs Market By value: Size and Forecast (2018-2028)
13.3 Europe Pain Management Drugs Market
13.4 Europe Pain Management Drugs Market: Prominent Companies
13.5 Europe Pain Management Drugs Market: Segment Analysis
13.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value
13.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
13.4 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
13.5 Market Segmentation By Availability (OTC, Prescription), By Value
13.6 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
13.7 Europe Pain Management Drugs Market: Country Analysis
13.8 Market Opportunity Chart of Europe Pain Management Drugs Market - By Country, By Value (Year-2028)
13.9 Competitive Positioning of Europe Pain Management Drugs Market - By Country
13.10 Germany Pain Management Drugs Market: Size and Forecast (2018-2028)
13.11 Germany Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.12 United Kingdom Pain Management Drugs Market: Size and Forecast (2018-2028)
13.13 United Kingdom Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.14 France Pain Management Drugs Market: Size and Forecast (2018-2028)
13.15 France Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.16 Spain Pain Management Drugs Market: Size and Forecast (2018-2028)
13.17 Spain Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.18 Italy Pain Management Drugs Market: Size and Forecast (2018-2028)
13.19 Italy Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
14 APAC Pain Management Drugs Market: An Analysis (2018-2028)
14.1 Assessment of Macro-Economic Indicators of APAC Pain Management Drugs Market
14.2 APAC Pain Management Drugs Market By value: Size and Forecast (2018-2028)
14.3 APAC Pain Management Drugs Market
14.4 APAC Pain Management Drugs Market: Prominent Companies
14.5 APAC Pain Management Drugs Market: Segment Analysis
14.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs) , Narcotics (opioids), Others) By Value
14.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
14.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
14.9 Market Segmentation By Availability (OTC, Prescription), By Value
14.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
14.11 APAC Pain Management Drugs Market: Country Analysis
14.12 Market Opportunity Chart of APAC Pain Management Drugs Market - By Country, By Value (Year-2028)
14.13 Competitive Positioning of APAC Pain Management Drugs Market - By Country
14.14 China Pain Management Drugs Market: Size and Forecast (2018-2028)
14.15 China Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
14.16 Japan Pain Management Drugs Market: Size and Forecast (2018-2028)
14.7 Japan Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
14.8 India Pain Management Drugs Market: Size and Forecast (2018-2028)
14.9 India Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
15. Middle East and Africa Pain Management Drugs Market
15.1 Assessment of Macro-Economic Indicators of MEA Pain Management Drugs Market
15.2 Middle East and Africa Pain Management Drugs Market By value: Size and Forecast (2018-2028)
15.3 Market Segmentation By Drug Type (Antibiotics, Antifungals, Astringents, Antipruritic, Analgesics, Others)
15.4 Market Segmentation By Route of Administration (Skin Disease, Pain Management, Eye and Ear Care, Others), By Value
15.5 Market Segmentation By End use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Others), By Value
15.6 Market Segmentation By Availability (Prescription, Over The Counter (OTC), Others), By Value
15.7 Market Segmentation By Sales Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Value
16. Global Pain Management Drugs Market Dynamics
16.1 Global Pain Management Drugs Market Drivers
16.2 Global Pain Management Drugs Market Restraints
16.3 Global Pain Management Drugs Market Trends
17. Market Attractiveness and Strategic Analysis
17.1 Market Attractiveness Chart of Global Pain Management Drugs Market - By Drug Type (2028)
17.2 Market Attractiveness Chart of Global Pain Management Drugs Market - By Route of Administration (2028)
17.3 Market Attractiveness Chart of Global Pain Management Drugs Market - By End-use (2028)
17.4 Market Attractiveness Chart of Global Pain Management Drugs Market - By Availability (2028)
17.5 Market Attractiveness Chart of Global Pain Management Drugs Market - By Sales Channel (2028)
17,6 Market Attractiveness Chart of Global Pain Management Drugs Market - By Region (2028)
18. Competitive Landscape
18.1 Market Share of global leading companies
19. Company Profiles (Business Description, Financial Analysis, Business Strategy)
19.1 Pfizer Inc.
19.2 Johnson & Johnson
19.3 GSK plc.
19.4 Bristol-Myers Squibb Company
19.5 Bayer AG
19.6 Boehringer Ingelheim
19.7 AbbVie Inc.
19.8 Teva pharmaceuticals
19.9 Sanofi
19.10 Amgen
Request Sample 
Request Discount 
Inquire Before Buy
